Post-market surveillance is a vital component of maintaining safety in the medical device...
- Hidden figures: lifting the lid on medical device failure reporting
- AI tool for smart speakers could respond to nearly half of cardiac arrests
- Veolity platform may accelerate expansion of NHS lung health checks
- Selling into the NHS: HEE’s top tips for medtech companies
- Dilemmas in regulating brain-computer interface devices
Micronova: Your Cleanroom’s Worth It
In today's world, the call for controlled manufacturing is standard across a wide range of industries. Processing and cleaning controls continue to grow ever more stringent in biotechnology and pharmaceutical production - at the same time engineers in wafer production and nanotechnology search for methods to attain higher yields.
Hidden figures: lifting the lid on medical device failure reporting
Post-market surveillance is a vital component of maintaining safety in the medical device market, but recent controversies have highlighted transparency concerns around device failure reporting. Is there too much secrecy in the reporting processes of regulators like the FDA, and how can the situation be improved?
Remote patient monitoring set to skyrocket in the US
Earlier this year, the US Department of Health and Human Services updated its reimbursement plans for RPM services, allowing them to be reimbursed.
AI tool for smart speakers could respond to nearly half of cardiac arrests
Researchers at the University of Washington have developed a new contactless artificial intelligence (AI) tool to monitor at-risk patients for cardiac arrest, even when they’re asleep.
Digitally connected patient support programmes are gaining momentum
Digital technology has been increasingly enabling a patient-centric model, which pharma companies need to adopt in order to remain relevant and deliver better health outcomes.
Veolity platform may accelerate expansion of NHS lung health checks
Medical imaging software provider MeVis Medical Solutions is in talks with NHS England about how the company’s Veolity software can help in the roll out of the NHS’s lung health check programme.
Selling into the NHS: HEE’s top tips for medtech companies
Med tech companies are major drivers of innovation in healthcare, however, they face a range of challenges and barriers when cracking into the UK’s primary healthcare provider, the NHS. Allie Nawrat talks to NHS innovation hub Health Enterprise East’s director of medtech consulting and business development Joop Tanis about gaining traction in the NHS.
Dilemmas in regulating brain-computer interface devices
The FDA has published guidance laying out how brain-computer interface devices are to be regulated. These devices have enormous potential for returning mobility and independence to patients, but a lot remains unknown. Allie Nawrat finds out more.
Zoll Medical launches heart failure management system
Zoll Medical has announced the launch of and first patient prescription for its Zoll µCor heart failure and arrhythmia management system (HFAMS).
Abbott’s FreeStyle device helps significantly reduce glucose levels
Abbott has reported that its continuous glucose monitoring (CGM) system FreeStyle Libre significantly minimised haemoglobin A1c (HbA1c) levels in type 2 diabetes patients on intensive insulin therapy.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Rolf Rihs has been working at assembly system manufacturer Mikron Automation for nearly 17 years. Over that time, he has…